View By Professional Interest Track

            Collaborative       Nurse       Practice Management       Psychology       TWP (Begins Nov. 1)
Vladimir Maletic, MD, PA
Founding Member, INEA; Clinical Professor of Neuropsyciatry and Behavioral Science, University of South Carolina School of Medicine, Columbia; Consulting Associate, Division of Child and Adolescent Psychiatry, Duke University

Sunday, November 1 01:15 - 02:25 p.m.
TWP 100.0 - Understanding the Mind-Body Relationship, Part I
1.25 credits - Room: Lagoon Ballroom
Vladimir Maletic, MD, PA, Founding Member, INEA; Clinical Professor of Neuropsyciatry and Behavioral Science, University of South Carolina School of Medicine, Columbia; Consulting Associate, Division of Child and Adolescent Psychiatry, Duke University

Focuses on defining the complex interactions between multiple vulnerability genes and environmental adversity, resulting in mood disorders. Vulnerability genes result in functional and structural frailty of the circuits involved in regulation of mood and stress response. Repeated distress disrupts the ability of these brain circuits to maintain homeostasis and organize adaptive responses - producing disease symptoms.

Upon the completion of this activity, participants will be able to:

  1. Describe the structural and functional changes that occur during the progression of stress and mood disorders.
  2. Optimize pain management by understanding the relationship between chronic pain and mood disorders
Sunday, November 1 04:15 - 04:45 p.m.
TWP 120.0 - Understanding the Mind-Body Relationship, Part 2
1.00 (With Q&A) credits - Room: Lagoon Ballroom
Vladimir Maletic, MD, PA, Founding Member, INEA; Clinical Professor of Neuropsyciatry and Behavioral Science, University of South Carolina School of Medicine, Columbia; Consulting Associate, Division of Child and Adolescent Psychiatry, Duke University

Describes the somato-psychic aspects of mood disorders. Products of perturbed autonomic, neuro-endocrine and neuro-immune regulation reach the brain. Here these compounds, generated in the periphery, impact on delicate communication between the various types of glia cells and neurons. Ensuing disturbance in synaptic function and intra-cellular signaling further compromises the ability of critical brain circuits to re-establish homeostasis-thus augmenting the disease process.

Upon the completion of this activity, participants will be able to:

  1. Describe the structural and functional changes that occur during the progression of stress and mood disorders.
  2. Recognize the importance of full symptomatic and functional recovery (ie remission) as an optimal treatment outcome of mood disorders.
Sunday, November 1 04:45 -05:15 p.m.
TWP 130.0 - Panel Question and Answer Session
- Room: Lagoon Ballroom
Vladimir Maletic, MD, PA, Founding Member, INEA; Clinical Professor of Neuropsyciatry and Behavioral Science, University of South Carolina School of Medicine, Columbia; Consulting Associate, Division of Child and Adolescent Psychiatry, Duke University
Charles Raison, MD, Associate Professor Clinical Director Mind-Body Program Department of Psychiatry and Behavioral Sciences Emory University School of Medicine Atlanta, GA
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas
Jon Draud, MD, MS, Private Practice, Psychopharmacology and Adult Psychiatry, Heritage Medical Associates, PC; Medical Director, Psychiatry and Addiction Medicine Services, Baptist Hospital; Clinical Professor, Department of Psychology Vanderbilt University, Nashville, TN

Join the entire faculty of Treating the Whole Patient for an Extended Question and Answer session at the end of Day 1.

Monday, November 2 01:30-2:25 p.m.
TWP 230.0 - Panel Question and Answer Session
- Room: Lagoon Ballroom
Vladimir Maletic, MD, PA, Founding Member, INEA; Clinical Professor of Neuropsyciatry and Behavioral Science, University of South Carolina School of Medicine, Columbia; Consulting Associate, Division of Child and Adolescent Psychiatry, Duke University
Charles Raison, MD, Associate Professor Clinical Director Mind-Body Program Department of Psychiatry and Behavioral Sciences Emory University School of Medicine Atlanta, GA
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas
Jon Draud, MD, MS, Private Practice, Psychopharmacology and Adult Psychiatry, Heritage Medical Associates, PC; Medical Director, Psychiatry and Addiction Medicine Services, Baptist Hospital; Clinical Professor, Department of Psychology Vanderbilt University, Nashville, TN

Join the entire faculty of Treating the Whole Patient for an Extended Question and Answer session at the end of Day 2.

Tuesday, November 3 12:15-2:15 p.m.
270 - Depression and Pain: Advances in Neurobiology and Treatment I PD RX
1.5 credits - Room: Mandalay Bay Ballroom GH
Vladimir Maletic, MD, PA, Founding Member, INEA; Clinical Professor of Neuropsyciatry and Behavioral Science, University of South Carolina School of Medicine, Columbia; Consulting Associate, Division of Child and Adolescent Psychiatry, Duke University
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas

The session will provide participants with strategies for improving the management of comorbid depression as well as chronic pain and other physical symptoms.

12:15PM-12:45 p.m. Lunch
12:45-2:15 p.m. Symposium

This activity is supported by an educational grant from Eli Lilly and Company.

This activity is jointly sponsored by The Albert Einstein College of Medicine with Montefiore Medical Center and CME LLC. The Institute for Continuing Healthcare Education is the content provider.

  Terms of Service     Privacy     Advertising
  ©2009 CME LLC